Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1060
-
Total 13F shares, excl. options
-
171M
-
Shares change
-
-3.65M
-
Total reported value, excl. options
-
$40.4B
-
Value change
-
-$1.01B
-
Put/Call ratio
-
1.19
-
Number of buys
-
473
-
Number of sells
-
-587
-
Price
-
$236.38
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2019
1,301 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q1 2019.
BIOGEN INC. - Common Stock (BIIB) has 1,060 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171M shares
.
Largest 10 shareholders include BlackRock Inc. (16.3M shares), VANGUARD GROUP INC (15M shares), PRIMECAP MANAGEMENT CO/CA/ (14.6M shares), STATE STREET CORP (8.75M shares), Clearbridge Investments, LLC (8.59M shares), WELLINGTON MANAGEMENT GROUP LLP (5.21M shares), Capital World Investors (4.9M shares), AQR CAPITAL MANAGEMENT LLC (4.22M shares), Invesco Ltd. (3.23M shares), and GEODE CAPITAL MANAGEMENT, LLC (3.04M shares).
This table shows the top 1060 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.